Frank Rauscher
14Patents
7h-index
14Co-inventors
63Inventor score
Filing activity: Jul 5, 1977 → Oct 3, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4679553A | Venipuncture site protector | Emerging Cross-Sectional Technologies | 37 | Expired |
| USD293717S | Venipuncture site protector | General | 33 | Expired |
| US5622835A | WT1 monoclonal antibodies | Emerging Cross-Sectional Technologies | 25 | Expired |
| US5633142A | WT1 monoclonal antibodies and methods of use therefor | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4198626A | Intravenous alarm device | Physics | 18 | Expired |
| US7833506B2 | Process for the synthesis of nanosize metal-containing nanoparticles and nanoparticle dispersions | Emerging Cross-Sectional Technologies | 8 | Active |
| US4132330A | Motor powered paste dispenser | Performing Operations; Transporting | 8 | Expired |
| US6307035A | BRCA1 associated polynucleotide (BAP-1) and uses therefor | Chemistry; Metallurgy | 4 | Expired |
| US9532959B2 | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | Human Necessities | 0 | Active |
| US8168745B2 | Process for the preparation of poly- and oligothiophenes on an industrial scale | Chemistry; Metallurgy | 0 | Active |
| US8394916B2 | Method for the production of thiophene oligomers | Chemistry; Metallurgy | 0 | Active |
| US12268443B2 | Therapeutic laser system and method of use for activating the tissue stem cell niche for the treatment of medical conditions | Human Necessities | 0 | Active |
| US10010514B2 | Pharmaceutical formulation for reducing frequency of urination and method of use thereof | Human Necessities | 0 | Active |
| US12404307B2 | Methods and compositions for use of recombinant bacterial effector proteins as anti-inflammatory agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.